Community acquired pneumonia incidence among children less than 5 years of age in Concordia, Argentina: vaccination impact
Objective. To measure the effectiveness of pneumococcal conjugated vaccine (PCV13) against Community Acquired Pneumonia (CAP) and invasive pneumococcal disease, 2 years after the vaccine (2+1) was included into the National Immunization Program of Argentina, and to describe variables associated with...
Main Authors: | Raúl O. Ruvinsky, Analía Rearte, Judit Kupervaser, Fernando Gentile, Adriana Haidar, Maria E. Cafure, Maria Elisa Tito, Federico Avaro, Cristina Cortiana, Hugo Cozzani, Omar Véliz, Sofia Fossati, Mabel Regueira, Carla Vizzotti |
---|---|
Format: | Article |
Language: | English |
Published: |
Pan American Health Organization
2018-11-01
|
Series: | Revista Panamericana de Salud Pública |
Subjects: | |
Online Access: | http://iris.paho.org/xmlui/handle/123456789/49588 |
Similar Items
-
Eventos adversos após vacinação contra o pneumococo Adverse events after pneumococcal vaccination
by: Maria Rita Donalisio, et al.
Published: (2007-02-01) -
Nasopharyngeal Pneumococcal Density and Evolution of Acute Respiratory Illnesses in Young Children, Peru, 2009–2011
by: Roger R. Fan, et al.
Published: (2016-11-01) -
Economic aspects of hospital treated pneumococcal pneumonia and the results of Pneumo 23 vaccine use in Serbia
by: Adžić Tatjana, et al.
Published: (2008-01-01) -
Pneumococcal Serogroups Causing the Most of the Invasive Diseases in Kayseri
by: Duygu EŞEL, et al.
Published: (2002-03-01) -
Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogotá, Colombia
by: David Felipe Severiche-Bueno, et al.
Published: (2021-04-01)